Synthiko Formulations & Pharma Private Limited
About Synthiko Formulations & Pharma Private Limited
Data last updated:
Synthiko Formulations & Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2007PTC168635. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Mahesh Jaylal Dadhia and Poonam Gupta.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 23 Vaibhav Industrial Estate Opp Onida House Mhakali Caves Road Andheri (E), Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2020, the company reported a revenue of ₹2.13 Cr, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹41.23 Lakh (net margin -19.4%) and EBITDA of -₹32.39 Lakh (EBITDA margin -15.2%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹1.48 Cr on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Synthiko Formulations & Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address23 Vaibhav Industrial Estate Opp Onida House Mhakali Caves Road Andheri (E), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synthiko Formulations & Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synthiko Formulations & Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synthiko Formulations & Pharma Private Limited, buy the company report.
Financials of Synthiko Formulations & Pharma Private Limited
FY 2020 filings availableSynthiko Formulations & Pharma Private Limited reported revenue of ₹2.13 Cr (down 54% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 54% fall in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.13 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹32.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹41.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.2% | ||||
| Net Profit Margin | -19.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synthiko Formulations & Pharma Private Limited, buy the company report.
Board of directors of Synthiko Formulations & Pharma Private Limited
Synthiko Formulations & Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Jaylal Dadhia | Director | 12 Mar 2007 | 19 Years 7 Months | Current |
| Poonam Gupta | Director | 29 Sep 2018 | 8 Years 0 Months | Current |
Peer comparison
Synthiko Formulations & Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Relief Lab Private Limited | ₹2.13 Cr (FY 2021) | -56.0% | Nagur, Maharashtra, India | |||
| Synthiko Formulations & Pharma Private Limitedthis company | ₹2.13 Cr (FY 2020) | -₹41.23 Lakh | -19.4% | -54.0% | Mumbai, Maharashtra, India | |
| Dr Patel Pharmaceutical Private Limited | ₹2.12 Cr (FY 2024) | 168.0% | Vadodara, Gujarat, India | |||
| Naveen Life Sciences (India) Private Limited | ₹2.11 Cr (FY 2025) | 1.0% | Bhiwandi, Maharashtra, India |
To see the full peer comparison of Synthiko Formulations & Pharma Private Limited, buy the company report.
Auditor
Synthiko Formulations & Pharma Private Limited is audited by BAJAJ & GOYANKA for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAJAJ & GOYANKA | FY 2019 | 019291C |
Shareholding
The shareholding of Synthiko Formulations & Pharma Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synthiko Formulations & Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2019 | 100248840 | Others | ₹53 Lakh | Open | |
| 02 Jun 2012 | 10363551 | Indian Overseas Bank | ₹95 Lakh | Open |
To see the full charge records of Synthiko Formulations & Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Synthiko Formulations & Pharma Private Limited has 13 court cases on record: 1 filed by Synthiko Formulations & Pharma, 12 filed against it. 1 case is pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 0 |
| High courts | 1 | 0 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Deputy Labour Commissioner and Others | Pending |
| District court, Thane, Maharashtra | Court case (Spl.Sum.Suit) | Filed against the company by M/S. Signature Phytochemical Industries | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by an individual | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Signa Medi | Disposed |
To see the full case history of Synthiko Formulations & Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synthiko Formulations & Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synthiko Formulations & Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Synthiko Formulations & Pharma Private Limited, buy the company report.
Recent activity
Synthiko Formulations & Pharma Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Hirendrakumar Ghanshyamlal Kanabar ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Synthiko Formulations & Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 March 2007 (19+ years old) and is registered under CIN U24233MH2007PTC168635.
Synthiko Formulations & Pharma has 2 current directors:
- Mahesh Jaylal Dadhia - Director
- Poonam Gupta - Director
The latest financial statements of Synthiko Formulations & Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.
No. Synthiko Formulations & Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Synthiko Formulations & Pharma is U24233MH2007PTC168635. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synthiko Formulations & Pharma has 13 court cases on record: 1 filed by the company and 12 filed against it. 1 is pending. Most are in the district courts.
Synthiko Formulations & Pharma was incorporated on 12 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Synthiko Formulations & Pharma by revenue are Relief Lab Private Limited, Dr Patel Pharmaceutical Private Limited, Naveen Life Sciences (India) Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hirendrakumar Ghanshyamlal Kanabar ceased to be Additional Director on 29 Sep 2018. Poonam Gupta was appointed as Director on 29 Sep 2018. Sheela Mahesh Dadhia ceased to be Director on 07 Sep 2018. Synthiko Formulations & Pharma has 4 board changes on record in total.
The registered office of Synthiko Formulations & Pharma is at 23 Vaibhav Industrial Estate Opp Onida House Mhakali Caves Road Andheri E, Mumbai, Maharashtra, India – 400093.
Synthiko Formulations & Pharma operates in the pharma industry, in the drug formulation and development segment.